Digital Application-Based Nursing Intervention
Health Outcomes of Digital Application-Based Nursing Intervention in Kidney Transplant Recipients
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to evaluate the effect of a digital application-based nursing intervention on improving health outcomes among kidney transplant recipients. Following kidney transplantation, patients face critical, lifelong challenges that require strict adherence to immunosuppressive therapy and rigorous self-management behaviors to prevent graft rejection and mortality. This study introduces a dual-component nursing intervention comprising an illustrated educational booklet and the implementation of the "MyTherapy" mobile health application. The study aims to determine whether combining tailored patient education with real-time digital medication reminders and symptom tracking can successfully enhance medication adherence, improve daily self-management behaviors, and reduce the self-perceived burden among transplant recipients during their post-operative recovery phase.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2026
CompletedFirst Posted
Study publicly available on registry
July 14, 2026
CompletedStudy Start
First participant enrolled
July 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2028
July 14, 2026
July 1, 2026
1 year
July 8, 2026
July 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Medication Adherence
Medication adherence will be assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8). Total scores range from 0 to 8, where higher scores indicate better adherence levels (high adherence = 8, medium adherence = 6 to \<8, low adherence = \<6).
Baseline, 1 month, and 3 months post-intervention
Secondary Outcomes (2)
Change in Patient Self-Management Behaviors
Baseline, 1 month, and 3 months post-intervention
Change in Self-Perceived Burden
Baseline, 1 month, and 3 months post-intervention
Study Arms (1)
Experimental group
EXPERIMENTALKidney transplant recipients in this single group receive a digital nursing intervention consisting of the MyTherapy mobile application for medication reminders and symptom tracking, accompanied by an illustrated educational booklet in simple Arabic covering essential post-transplant self-care and lifestyle guidelines.
Interventions
A multi-component, digital application-based nursing intervention designed to improve post-transplant health outcomes. The intervention consists of two main components: 1) The MyTherapy smartphone application, utilized by patients to receive tailored medication reminders, track post-operative symptoms, and maintain daily health logs. 2) A comprehensive, illustrated educational booklet written in simple Arabic to guide patients on essential post-transplant self-care, medication compliance, vital signs self-monitoring, and necessary lifestyle modifications.
Eligibility Criteria
You may qualify if:
- Adult kidney transplant recipients (aged 20-65 years).
- Patients transplanted between June 2024 and June 2026 who are currently maintained on regular outpatient follow-up.
- Patients who have access to a smartphone compatible with the mobile application.
You may not qualify if:
- Patients and family members who are illiterate or unable to use the mobile application effectively due to literacy limitations.
- Patients with severe cognitive impairment or psychiatric conditions
- Patients with auditory and visual disorders.
- Patients with failed graft.
- Patients who are lost to follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University Urology Hospital
Asyut, 71515, Egypt
Study Officials
- STUDY CHAIR
Magda Ahmed Mohamed, PhD
Faculty of Nursing, Assiut University
- STUDY CHAIR
Rabea Ahmed Gadelkareem, MD
Assiut University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Lecturer of medical surgical nursing
Study Record Dates
First Submitted
July 8, 2026
First Posted
July 14, 2026
Study Start
July 15, 2026
Primary Completion (Estimated)
July 15, 2027
Study Completion (Estimated)
May 1, 2028
Last Updated
July 14, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share